EBMT-EHA CAR-T 2019 | Challenges of CAR T-cell therapy for solid cancers

Claudia Rössig

While CAR T-cell therapy has shown promising results for hematological malignancies, Claudia Rössig, MD University of Münster, Münster, Germany, discusses the issues with using this therapy for solid cancers. Dr Rössig was speaking from the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video